Integrative high-throughput studies to develop novel targets and drugs for the treatment of advanced prostate cancer.
开展综合高通量研究,开发治疗晚期前列腺癌的新靶点和药物。
期刊:Genes and Diseases
影响因子:9.4
doi:10.1016/j.gendis.2025.101732
Li Xuehui, Shen Yanting, Zhang Na, Lu Dong, Ding Shuhua, Wu Fanchen, Song Xiaowei, Zhou Xiangru, Lin Shan, Xu Huan, Wang Zhong, Yuan Fuwen